The 7th Annual Mild Cognitive Impairment Symposium: Part 3

There’s a great deal of interest in genetic testing to assess the risk of developing Alzheimer’s and other common diseases.  Although some scientists argue that we don’t yet know enough to really estimate risk based on a genetic test, some companies offer testing and risk assessment now.

Should someone diagnosed with Mild Cognitive Impairment undergo genetic testing to find out if he has a neurodegenerative disease such as Alzheimer’s or Parkinson’s?  The third report from the Mild Cognitive Impairment Symposium is a summary of a presentation on this topic by Dr. Owen Ross, Assistant Professor of Neuroscience at Mayo Clinic College of Medicine.

Comments

[Don Moyer]

See also:
http://www.alzforum.org/new/detail.asp?id=2104